Company news

Lifecore Biomedical, Inc. news in 2026

Lifecore Biomedical, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update

November 4, 2026

Lifecore Biomedical to Participate at Upcoming Industry Conferences

October 7, 2026

Lifecore Biomedical to be acquired by Webster Equity Partners

September 29, 2026

Lifecore Biomedical to Participate at CPHI Global Conference

September 3, 2026

Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company

September 2, 2026

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

August 5, 2026

Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026

July 29, 2026

Lifecore Biomedical Signs Three New Customer Agreements

July 28, 2026

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

June 15, 2026

Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer

June 2, 2026

Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference

May 21, 2026

Lifecore Biomedical to Participate at CDMO Live Europe

May 12, 2026

Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update

May 6, 2026

Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026

April 29, 2026

Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit

April 8, 2026

Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer

March 25, 2026

Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company

March 22, 2026

Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update

March 15, 2026

Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum

March 10, 2026

Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026

March 9, 2026

Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment

March 3, 2026

Lifecore Biomedical to Participate at DCAT Week 2026

February 17, 2026

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)

January 19, 2026

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

Calls in 2026

Decks in 2026